ARDELYX INC

ARDX · NASDAQ

Updated at 2026-11-16 20:53:41

$3.10+0.32%
Today's High
$3.13
Today’s Low
$3.04
ARDELYX INC (ARDX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$3.14
Previous Close
$3.09
Volume
2.38M
Market Cap
$776.74M
P/E Ratio
--
EPS
$-0.22

Previous Day Range

$3.05$3.15

52-Week Range

$2.80$8.40

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
400 FIFTH AVENUE, WALTHAM, MA, UNITED STATES, 02451
Country
US
Listing Date
2014-06-19
Fiscal Year End
December
Shares Outstanding
249.19M
CIK
0001437402

Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.

Financial Metrics

Revenue

2026-09-30

$127.65M

2026-06-30

$120.87M

2026-03-31

$94.47M

2025-12-31

$125.21M

Operating Expenses

2026-09-30

$119.09M

2026-06-30

$127.54M

2026-03-31

$122.45M

2025-12-31

$108.34M

Net Income

2026-09-30

-$737K

2026-06-30

-$16.72M

2026-03-31

-$37.6M

2025-12-31

-$407K

Net Profit Margin

2026-09-30

-0.57%

2026-06-30

-13.83%

2026-03-31

-39.8%

2025-12-31

-0.32%

Earnings Per Share

2026-09-30

$0.00

2026-06-30

$-0.07

2026-03-31

$-0.15

2025-12-31

$0.00

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

$4.02M

2026-06-30

-$11.05M

2026-03-31

-$29.76M

2025-12-31

$8.09M

Effective Tax Rate

2026-09-30

-13.91%

2026-06-30

-0.66%

2026-03-31

-0.02%

2025-12-31

-1.75%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.